EA004302B9 - β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ - Google Patents

β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ

Info

Publication number
EA004302B9
EA004302B9 EA200200119A EA200200119A EA004302B9 EA 004302 B9 EA004302 B9 EA 004302B9 EA 200200119 A EA200200119 A EA 200200119A EA 200200119 A EA200200119 A EA 200200119A EA 004302 B9 EA004302 B9 EA 004302B9
Authority
EA
Eurasian Patent Office
Prior art keywords
carboline
drug products
compound
solvates
disclosed
Prior art date
Application number
EA200200119A
Other languages
English (en)
Other versions
EA200200119A1 (ru
EA004302B1 (ru
Inventor
Нил Р. Андерсон
Керри Дж. Хартоэр
Марта А. Крэл
Грегори А. Стивенсон
Original Assignee
ЛИЛЛИ АЙКОС эЛ-эЛ-Си
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA004302(B9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ЛИЛЛИ АЙКОС эЛ-эЛ-Си filed Critical ЛИЛЛИ АЙКОС эЛ-эЛ-Си
Publication of EA200200119A1 publication Critical patent/EA200200119A1/ru
Publication of EA004302B1 publication Critical patent/EA004302B1/ru
Publication of EA004302B9 publication Critical patent/EA004302B9/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

Описано соединение структурной формулы (I)и его фармацевтически приемлемые соли и сольваты, где соединение находится в форме свободного лекарственного средства в виде частиц.
EA200200119A 1999-08-03 2000-08-01 β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ EA004302B9 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14704899P 1999-08-03 1999-08-03
PCT/US2000/020981 WO2001008688A2 (en) 1999-08-03 2000-08-01 Beta-carboline drug products

Publications (3)

Publication Number Publication Date
EA200200119A1 EA200200119A1 (ru) 2002-06-27
EA004302B1 EA004302B1 (ru) 2004-02-26
EA004302B9 true EA004302B9 (ru) 2019-01-31

Family

ID=22520112

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200119A EA004302B9 (ru) 1999-08-03 2000-08-01 β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ

Country Status (33)

Country Link
EP (1) EP1200092B1 (ru)
JP (1) JP4456788B2 (ru)
KR (1) KR20020063842A (ru)
CN (2) CN101134019A (ru)
AR (1) AR033953A1 (ru)
AT (1) ATE264680T1 (ru)
AU (1) AU773666B2 (ru)
BR (1) BR0012901A (ru)
CA (1) CA2380087C (ru)
CO (1) CO5200849A1 (ru)
CZ (1) CZ300151B6 (ru)
DE (1) DE60010089T2 (ru)
DK (1) DK1200092T3 (ru)
DZ (1) DZ3180A1 (ru)
EA (1) EA004302B9 (ru)
ES (1) ES2220506T3 (ru)
HK (1) HK1044278B (ru)
HR (1) HRP20020091B1 (ru)
HU (1) HU229443B1 (ru)
IL (1) IL147642A0 (ru)
MX (1) MXPA02001197A (ru)
MY (1) MY125428A (ru)
NO (1) NO321602B1 (ru)
NZ (1) NZ516613A (ru)
PE (1) PE20010480A1 (ru)
PL (1) PL199469B1 (ru)
PT (1) PT1200092E (ru)
SK (1) SK286365B6 (ru)
SV (1) SV2002000137A (ru)
TW (1) TWI235658B (ru)
UA (1) UA71629C2 (ru)
WO (1) WO2001008688A2 (ru)
ZA (1) ZA200200825B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4491200A (en) * 1999-08-03 2001-02-19 Lilly Icos Llc Beta-carboline pharmaceutical compositions
US8063214B2 (en) * 2004-10-28 2011-11-22 Dr. Reddy's Laboratories Limited Polymorphic forms of tadalafil
PL1808164T3 (pl) * 2006-01-05 2009-06-30 Teva Pharma Sposób z granulacją na mokro do wytwarzania kompozycji farmaceutycznych aripiprazolu
DE102007028869A1 (de) 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
MD4009C2 (ru) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Использование 1-метил-4-(N-метиламинобутил-4)-β-карболина в качестве противотуберкулезного средства
DE102009033396A1 (de) 2009-07-16 2011-01-20 Ratiopharm Gmbh Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
DE102009035211A1 (de) 2009-07-29 2011-02-17 Ratiopharm Gmbh Copräzipitate umfassend einen Phosphodiesterase-5-Inhibitor (PDE-5-Inhibitor) und einen pharmazeutisch verträglichen Trägerstoff, ihre Herstellung und Verwendung
WO2012085927A2 (en) * 2010-12-02 2012-06-28 Mylan Laboratories, Limited Tadalafil compositions
WO2012095151A1 (en) 2010-12-23 2012-07-19 Zaklady Farmaceutyczne Polpharma Sa Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof
WO2012107092A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
RU2013141446A (ru) 2011-02-10 2015-03-20 Синтон Бв Фармацевтическая композиция, содержащая тадалафил и циклодекстрин
WO2012107090A1 (en) 2011-02-10 2012-08-16 Synthon Bv Granulated composition comprising tadalafil and a disintegrant
JP5930686B2 (ja) * 2011-12-07 2016-06-08 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
KR102268696B1 (ko) 2012-03-15 2021-06-23 메르크 파텐트 게엠베하 전자 소자
WO2014003678A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil
WO2014003677A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising solid dispersion particles containing tadalafil
CN105310984A (zh) * 2014-06-10 2016-02-10 合肥贝霓医药科技有限公司 一种pde5抑制剂的超微粉体及其制备方法
EP3111929B1 (en) * 2014-06-24 2018-08-29 Wooshin Labottach Co., Ltd. Oral disintegrating film formulation containing tadalafil and preparation method therefor
SI3172207T1 (sl) 2014-07-23 2019-06-28 Krka D.D., Novo Mesto Proces za pripravo zaviralca CGMP-fosfodiesteraze in oralne farmacevtske formulacije, ki obsega koprecipitate tadalafila
JP2016106139A (ja) * 2016-03-07 2016-06-16 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
CA3086881A1 (en) * 2017-12-26 2019-07-04 Ftf Pharma Private Limited Liquid oral formulations for pde v inhibitors
HUE052118T2 (hu) 2018-01-10 2021-04-28 Gap S A Tadalafil szuszpenziót tartalmazó lágy zselatinkapszulák
CN110638770B (zh) * 2019-10-25 2022-04-05 株洲千金药业股份有限公司 他达拉非片剂的制备方法及以该方法制得的片剂
WO2023227185A1 (en) * 2022-05-27 2023-11-30 Rontis Hellas S.A. Improved pharmaceutical composition containing tadalafil and nanomilling process for the preparation thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2293103A (en) * 1994-10-06 1996-03-20 Cephalon Inc Modafinil composition of defined particle size
WO1996038131A1 (en) * 1995-06-02 1996-12-05 Glaxo Group Limited Method of producing a solid dispersion of a poorly water soluble drug

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2293103A (en) * 1994-10-06 1996-03-20 Cephalon Inc Modafinil composition of defined particle size
WO1996038131A1 (en) * 1995-06-02 1996-12-05 Glaxo Group Limited Method of producing a solid dispersion of a poorly water soluble drug

Also Published As

Publication number Publication date
NZ516613A (en) 2003-08-29
DE60010089D1 (de) 2004-05-27
CZ300151B6 (cs) 2009-02-25
HK1044278A1 (en) 2002-10-18
AU773666B2 (en) 2004-06-03
CO5200849A1 (es) 2002-09-27
AR033953A1 (es) 2004-01-21
SK286365B6 (sk) 2008-08-05
ZA200200825B (en) 2003-04-30
PE20010480A1 (es) 2001-05-26
MY125428A (en) 2006-07-31
SV2002000137A (es) 2002-06-07
HUP0202781A3 (en) 2003-10-28
HK1044278B (zh) 2004-10-08
NO321602B1 (no) 2006-06-12
PL353268A1 (en) 2003-11-03
EP1200092A2 (en) 2002-05-02
DK1200092T3 (da) 2004-08-16
WO2001008688A2 (en) 2001-02-08
PT1200092E (pt) 2004-07-30
MXPA02001197A (es) 2003-02-12
DE60010089T2 (de) 2004-10-14
CN1377270A (zh) 2002-10-30
CZ2002387A3 (cs) 2002-10-16
NO20020531L (no) 2002-04-03
PL199469B1 (pl) 2008-09-30
ES2220506T3 (es) 2004-12-16
HRP20020091B1 (en) 2006-02-28
UA71629C2 (en) 2004-12-15
AU6508400A (en) 2001-02-19
BR0012901A (pt) 2002-04-16
HUP0202781A2 (hu) 2002-12-28
EP1200092B1 (en) 2004-04-21
HRP20020091A2 (en) 2004-02-29
TWI235658B (en) 2005-07-11
EA200200119A1 (ru) 2002-06-27
CA2380087C (en) 2007-05-01
EA004302B1 (ru) 2004-02-26
WO2001008688A3 (en) 2001-08-16
SK1722002A3 (en) 2002-05-09
IL147642A0 (en) 2002-08-14
DZ3180A1 (fr) 2001-02-08
ATE264680T1 (de) 2004-05-15
KR20020063842A (ko) 2002-08-05
JP4456788B2 (ja) 2010-04-28
CA2380087A1 (en) 2001-02-08
HU229443B1 (en) 2013-12-30
NO20020531D0 (no) 2002-02-01
CN101134019A (zh) 2008-03-05
JP2003505510A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
EA004302B9 (ru) β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
GEP20022653B (en) Processes and Intermediates for Preparing Anti-Cancer Compounds
YU38802A (sh) Nova kompozicija i njena upotreba
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
GB9914486D0 (en) Medicaments
HUP0301834A3 (en) Use of heterocyclic dihydropyrimidine derivatives for the preparation of pharmaceutical compositions with potassim channel activity, novel derivatives and pharmaceutical compositions containing them
HK1026909A1 (en) Substituted phenyl derivatives, their preparation and use
MY136643A (en) Pyrimidine derivatives for inhibition of cell-proliferation
HK1049957A1 (en) 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
LU91433I2 (fr) "Tenofovir disoproxil et les sels, en particulier le fumarate, hydrates, tautomers et solvates en combination avec l'emtricitabine et l'efavirenz (ATRIPLA)
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
NZ515304A (en) Bradykinin receptor antagonists
WO2001035940A3 (en) Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
YU30603A (sh) Derivati premošćenog piperazina
TW200508199A (en) Novel compound
AU5290199A (en) Erythromycin derivatives with antibiotic activity
AU2002211493A1 (en) Indole derivatives as pde5-inhibitors
AU2001261707A1 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
BG106151A (en) Pharmaceutical complex
TWI255813B (en) Compounds for use as alphavbeta3 receptor antagonists
IL145041A0 (en) Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives
HUP0200993A3 (en) Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
HK1051845A1 (en) Substituted 1 and 2 naphthol mannich bases

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
QB4A Registration of a licence in a contracting state
MH4A Revocation of a eurasian patent in part
TH4A Publication of the corrected specification to eurasian patent
TK4A Corrections in published eurasian patents
MF4A Revocation of a eurasian patent as invalid entirely

Designated state(s): RU

MK4A Patent expired

Designated state(s): AM AZ BY KZ KG MD TJ TM